Blue Horseshoe Stocks: HEAR Review & More

Turtle Beach Corp. HEAR – Review

Our primary focus has always been to find near-term trading opportunities first, assigning longer-term calls a secondary priority. However, we’ve had quite a bit of good fortune this year in identifying stocks that have gone on to have considerable extended runs.

HEAR is one such stock, that we first signaled for observation on April 9th, at which time the stock was trading for as little as 2.76. Over the ensuing nine weeks, we have seen an incredible, near-continuous bull run that has resulted in new highs of 23.20 yesterday. That works out to an increase of 740% over a span of a little over two months!

Being in blue skies, there’s no telling what new highs we might see in HEAR; it’s certainly plausible to believe we may see our total observed gain reach a thousand percent at some point in the near future. At the rate things have been going, it’s certainly not an unreasonable thought.


H&R Block, Inc. HRB – Fresh Idea

We also want to provide a quick update on our bearish options idea from yesterday’s premarket report, the HRB Weekly $26-24 Puts. We formulated this range after noticing the stock getting kicked hard despite posting an earnings beat in the post-market on Tuesday.

HRB did gap down a little too far for the $26′s to see much action, but we had respectable chances to profit off of the other two contracts in the range. The $25 Puts ran from .65-1.05 for a gain of 62%, while the $24′s put up a double-bag performance with a 133% rip from .15-.35.


Galectin Therapeutics, Inc. GALT

We tagged GALT on Tuesday morning after noticing a big surge in activity, and its run has continued nicely over the course of the week.

We’ve now observed a solid 37% bullish move from 5.83-8.00, and will be on the lookout for the possibility of more new highs.


Extended Watchlist:
ENPH, CTRV, CODX, FCEL, ETSY, ONTX, MYSZ

Blue Horseshoe Stocks: UURAF Update & More

Ucore Rare Metals, Inc. UURAF – Update

We wanted to return to UURAF today, a company we covered last month, which is in the process of designing and building a rare earth material extraction facility near Ketchikan, Alaska which it believes could help the US end its dependency on China for rare earths.

UURAF’s Bokan – Dotson Ridge rare earth property is considered as having some of the richest deposits of rare earth materials in North America, and is so promising that the Alaskan government pledged a $145M funding package to assist in development of the property, including $30M for the new processing facility.

A few weeks ago, the company announced it would be executing a private placement to help cover general expenses as it continues to develop the Bokan property, and just yesterday, we saw that the company has completed the first portion of that deal, quickly making good on its earlier statement:

HALIFAX, Nova Scotia, June 11, 2018 (GLOBE NEWSWIRE) — Ucore Rare Metals Inc. (TSXV:UCU) (OTCQX:UURAF) is pleased to announce that further to its news release dated May 23, 2018, the Company has successfully closed the first tranche of its non-brokered private placement by issuing 6,344,074 units at a subscription price of $0.18 per Unit for gross proceeds of approximately $1,142,000. (>>View Full PR)
_____

VIDEO CHART:

We have also prepared a video presentation of the current UURAF chart.

We are going to be reviving our YouTube channel so after you’re finished viewing the following chart, be sure that you get subscribed with alerts activated, for more great content coming soon!


Tesla, Inc. TSLA – Options Idea

TSLA stock is getting a jolt after KeyBanc analysts predicted as much as a 50% rise in Tesla Model 3 deliveries, and as is the case whenever something causes a stir on the chart, we are going to be looking to take advantage of the situation using some weekly options ideas.

For TSLA, which just recently cracked through its 200DMA, we are going to be looking to the TSLA Weekly 337.50-347.50 Calls for potential quick-strike trades.


Extended Watchlist:
KNDI, SAGE, I, RIGL, GALT, TYME, APRI

Blue Horseshoe Stocks: NFLX Recap & More

Netflix, Inc. NFLX – Options Recap

On Tuesday morning after Netflix came out with its quarterly report and soundly exceeded expectations, we entered an options idea for the NFLX chain into the log in our premarket report.

We followed up with a recap of the gains made possible on Wednesday, which ranged from 65-100% but after a continuation of its bullish trend through yesterday, we observed some excellent new highs.24.50-

So we want to finish off the week by updating the figures on the total possible gains in our highlighted NFLX contracts, from Tuesday’s lows to yesterday’s highs.

$247.50 Calls – Range: 4.87-24.50 – Max Gain: 403%
$250 Calls – Range: 3.66-22.30 – Max Gain: 509%
$252.50 Calls – Range: 2.68-19.80 – Max Gain: 639%
$255 Calls - Range: 1.90-17.30 – Max Gain: 811%

_________

Fresh Idea:
Intel Corp. INTC Weekly $47.50-48.50*

*Please do not attempt to trade weekly options on a Friday unless you are an expert level trader with disposable funds. It’s one of the riskiest activities out there!



MannKind Corp. MNKD

We’ve been following MNKD for quite a long while, that’s why at the end of last month when we saw the stock fall to its lowest PPS since before the huge run back in the fall, we immediately signaled it as a bottom-watch play.

That was the morning of December 22nd, just prior to the holiday break. The stock saw its low of 2.30 the following session, on December 26th, and has since recovered much of the ground it had lost. Yesterday, possibly as the result of a short squeeze, the stock soared to a high of 4.05. That works out to a respectable 76% upswing in just one month’s time.

It remains to be seen if the stock can retest the impressive highs we saw from it back in October.


Extended Watchlist:
BOLD, ENRJ, HGT, RAS, LMFA, NBEV, MYSZ, GALT,

Blue Horseshoe Stocks: DAL, GALT Updates & More


Delta Air Lines, Inc. DAL  – Options Recap

We followed a range of Delta options beginning on Thursday morning, when we signaled the DAL Weekly $57-58 Calls in the wake of the company’s across-the-board Q4 earnings beat. We were glad to report on Friday that in a single session those three sets of contracts yielded gains ranging from roughly 780% to 1980%

Despite making such big moves already, Friday’s session brought more success for our tracked calls, so we wanted to open up this short trading week with a final recap on the maximum gains allowed by those excellent weekly contracts. The total ranges we observed over just two sessions were amazing.

$57 Calls – Range: .24-3.44 – Max Gain: 1313%
$57.50 Calls – Range: .14-2.96 – Max Gain: 2014%
$58 Calls – Range: .06-2.40 – Max Gain: 3900%


Galectin Therapeutics, Inc. GALT

We also want to swing back around for GALT, a stock we routinely tracked throughout 2017. It finished off that yea with a bang, and has continued its excellent run into 2018.

From lows it saw at the beginning of December at 1.28, to the new highs it made at the end of last week at 6.15 , GALT had executed a 380% increase in roughly five weeks!


Extended Watchlist:
NCTY, HEB, BB, OSIS, OTIV, HAWK

Blue Horseshoe Stocks: Fresh Options Ideas & More

First we’d like to apologize for our email list members for the absence of yesterday’s premarket report. Our service provider was shut down for the most of the day rendering us unable to send our daily report via email. This is an exceedingly rare event, but in these cases, you can always bookmark and visit BlueHorseshoeStocks.com just before market open, as all of our newsletters are archived there for easy reference.

Alcobra Ltd. ADHD

We did include ADHD in yesterday’s report, but since many of readers happened to miss it, we’ll back up to the next most recent mention, when we alerted the stock on September 29th.

The stock did see sub-1.00 prices that day, but took a couple more sessions to see its low of .96. Since then ADHD has been on a steady run-up, culminating in a new high of 2.17, which represented a very nice 127% move in a three week period.


PayPal Holdings, Inc. PYPL

We want to highlight a range of options for PYPL after the company posted its quarterly earnings after market close yesterday. The stock has been on a nearly continual rise all year long, and in premarket trading today, PYPL shares have rocketed into blue skies, setting a new annual high with each uptick.

As we often do in these post-earnings beat gap-up situations, we’ll identify a set of options contracts in the PYPL chain to observe as things kick off this morning, in this case, the PYPL Weekly $71-72.50 Calls* for potential quick strike trades today.

*Important: Never trade options with a weekly expiration on a Friday unless you’re an expert trader with disposable funds. It’s extremely risky.



AcelRx Pharmaceuticals, Inc. ACRX

ACRX recently fell off a cliff after the FDA rejected the company’s NDA for its Dsuvia drug, however ACRX believes it can meet the accompanying guidelines to eventually submit a successful application. We did alert that event in last Friday’s report, and meanwhile, the stock is gapping up this morning after having seen and bounced off of new annual lows yesterday. 

Recovering even a fraction of the ground it lost last week, could spell significant upswings for ACRX in coming sessions.


Extended Watchlist:
 AUPH, GALT, HMNY, INFI, ONVO, NEOT, BAC,